| 货号 | 规格 | 价格 | 上海 | 北京 | 珠海 | 重庆 | 武汉 | 购买数量 |
|---|---|---|---|---|---|---|---|---|
S86835-1mg促销 |
≥98% | ￥480.00 ￥432.00 |
4 | - | - | - | - |
|
S86835-5mg促销 |
≥98% | ￥870.00 ￥782.00 |
2 | - | - | - | - |
|
S86835-10mg促销 |
≥98% | ￥1440.00 ￥1290.00 |
2 | - | - | - | - |
|
S86835-25mg促销 |
≥98% | ￥3170.00 ￥2850.00 |
1 | - | - | - | - |
|
S86835-100mg促销 |
≥98% | ￥6700.00 ￥6030.00 |
货期：2-3天 | - | - | - | - |
|
| 产品描述： | McMMAF is a protective group-conjugated MMAF. MMAF is a potent tubulin polymerization inhibitor.It is a MMAF derivative having a Maleimidocaproyl linker (MC linker), which is ready to conjugate to antibody or other proteins or biopolymers. Mafodotin is a useful agent for make antibody drug conjugate (ADC) for targeted drug delivery. | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 靶点： | Microtubule Associated;MicrotubuleAssociated | ||||||||||||||||||||
| 参考文献： | 1. Polson AG, et al. Antibody-drug conjugates for the treatment of non-Hodgkin's lymphoma: target and linker-drug selection. Cancer Res. 2009 Mar 15;69(6):2358-2364. 2. Jianmin Fang, et al. Anti-her2 antibody and conjugate thereof. US 20160304621 A1. | ||||||||||||||||||||
| 溶解性： | Soluble in DMSO | ||||||||||||||||||||
| 保存条件： | 2-8℃ | ||||||||||||||||||||
| 配置溶液浓度参考： |
|
||||||||||||||||||||
| 注意： | 部分产品我司仅能提供部分信息，我司不保证所提供信息的权威性，仅供客户参考交流研究之用。 |
上海工商
沪公网安备 31011702002021号
危险品化学品经营许可证（不带存储）
营业执照(三证合一)
北京